Meteora Capital’s Medicus Sciences Acquisition Corp. Warrant MSACW Stock Holding History

Meteora Capital’s Portfolio MSACW Stock Details MSACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-62,749	Closed	-$5.65K	–	500
2022 Q4	$5.65K	Buy	62,749 +3,796	+6%	+$359	﹤0.01%	260
2022 Q3	$10K	Sell	58,953 -3,085	-5%	-$587	﹤0.01%	272
2022 Q2	$11K	Buy	+62,038	New	+$17.5K	﹤0.01%	358

Meteora Capital's MSACW Position: Q1 2023 in Review

Meteora Capital sold out of Medicus Sciences Acquisition Corp. Warrant (MSACW) in Q1 2023, closing a stake of 62,749 shares — an estimated $5.65K sold.

Meteora Capital first reported a position in MSACW in Q2 2022 and held it in 3 quarters. The position peaked at $11K in Q2 2022. 0 funds tracked by Wall St. Rank hold MSACW as of Q1 2023.

Meteora Capital reported no remaining Medicus Sciences Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Meteora Capital sold 62,749 Medicus Sciences Acquisition Corp. Warrant shares in Q1 2023, an estimated $5.65K.
Meteora Capital first reported a position in Medicus Sciences Acquisition Corp. Warrant in Q2 2022 and held it in 3 quarters.
Meteora Capital's Medicus Sciences Acquisition Corp. Warrant position peaked at $11K in Q2 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Warrant as of Q1 2023.

Based on Meteora Capital's 13F filing for Q1 2023, filed 15 May 2023.